Nanoparticle paves the way for new triple negative breast cancer drug
ScienceDaily | March 24, 2017
Professor El-Tanani discovered the peptide drug which blocks a protein known as RAN. High levels of RAN have been linked to aggressive tumour growth, cancer spread, resistance to chemotherapy and poor prognosis in a number of cancers, including triple negative breast cancer (TNBC).